Loading clinical trials...

Aminophylline Infusion on Pain Intensity After Ureterocopic Lithotripsy | Clinical Trials | Clareo Health

COMPLETEDNA

Aminophylline Infusion on Pain Intensity After Ureterocopic Lithotripsy

Effect of Intraoperative Aminophylline Infusion on Pain Intensity After Ureterocopic Lithotripsy Surgeries

NCT05705050•Tanta University

Summary

This study will be conducted to evaluate the effect of intraoperative systemic aminophylline infusion on pain intensity in patients undergoing ureteroscopic lithotripsy surgeries with ureteric stent placement at the end of the procedure.

Eligibility

Age

18 - 50 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Aged between 18 to 50 years
•American society of anesthesiology (ASA) physical status I - II
•Body mass index (BMI) less than 30.0 kg/m2
•Scheduled for ureteroscopic lithotripsy surgery with D-J ureteric stent placement at the end of procedure
•Under general anesthesia.

Exclusion Criteria

•1. Patients with central nervous system diseases, cardiovascular diseases, arrhythmias, cerebrovascular diseases, convulsions, renal impairment or hepatic dysfunction.
•2. Pregnancy or lactation.
•3. Patients with a history of allergy to aminophylline.
•4. Coffee consumption (more than 2 cups/day)
•5. Patients with opioid addiction or patients treated with B agonists, tranquilizers, or antidepressants.
•6. Short procedures less than 30 minutes or procedures not requiring D-J stent placement.

Locations (1)

Tanta University Hospitals

Tanta, ElGharbiaa, Egypt

Key Dates

Start Date

February 15, 2023

Primary Completion Date

June 18, 2023

Completion Date

June 19, 2023

Last Updated

June 27, 2023

Enrollment

ACTUAL participants

Conditions

AminophyllinePainUreterocopic Lithotripsy

Interventions

Aminophylline group

DRUG

Control group

OTHER

Effect of Virtual Reality on Patient's Comfort During Cardiac Electronic Device Implantation.

NCT06346132

Virtual RealityMedical Device+2 more

View study

RECRUITINGPHASE1

A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis

NCT07351968

Moderate Pain in Knee OsteoarthritisSevere Pain in Knee Osteoarthritis

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 27, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Aminophylline Infusion on Pain Intensity After Ureterocopic Lithotripsy

Inclusion Criteria

Exclusion Criteria

Effect of Virtual Reality on Patient's Comfort During Cardiac Electronic Device Implantation.

A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis

Comparison Between Tranversus Abdominis Plane (TAP) Block With Only Bupivacaine and TAP Block With Bupivacaine Plus Ketamine in Reducing Postoperative Pain After Total Abdominal Hystrectomy

Intertransverse Process Block to Improve Quality of Recovery and Pain Management in Adult Cardiac Surgical Patients

Evaluating Postoperative Pain and Antibacterial Effect of Ultrasonic and 980 nm Diode Laser Combination

Turkish Validity and Reliability of the Behavioral Indicators of Pain Scale(ESCID)